generalized pustular psoriasis

AnapstysBio’s imsidolimab Phase III trial’s results can bring it closer to approval
Clinical Trials Arena
Tue, 10/31/23 - 11:26 am
AnaptysBio
clinical trials
generalized pustular psoriasis
imsidolimab
Chasing Boehringer, Anaptys hits goal in pivotal rare skin disease trial, plans out-licensing deal
Fierce Biotech
Mon, 10/9/23 - 10:11 am
AnaptysBio
generalized pustular psoriasis
clinical trials
imsidolimab
Boehringer Ingelheim
Boehringer’s spesolimab data raises hope for serious skin disease
Pharmaforum
Sun, 12/26/21 - 11:14 pm
Boehringer Ingelheim
spesolimab
clinical trials
generalized pustular psoriasis